Phibro Animal Health (NASDAQ:PAHC) Stock Price Down 4.3% - Should You Sell?

Key Points

• Phibro Animal Health shares fell 4.3% to about $38.21 in mid-day trading, while trading volume was 87% below the average daily volume.
• Analyst sentiment has weakened: the consensus rating is now “Hold”, with a $47.67 target price after Citigroup cut its target from $62 to $44.
• The company exceeded quarterly expectations, reporting $0.85 in EPS versus $0.71 expected and $396.75 million in revenue versus $381.18 million expected. It also declared a quarterly dividend of $0.12 per share, representing a 1.2% yield.

Shares of Phibro Animal Health Corporation (NASDAQ:PAHC - Get Free Report) dropped 4.3% during mid-day trading on Thursday . The stock traded as low as $38.26 and last traded at $38.2050. 37,577 shares were traded during trading, a decline of 87% from the average daily volume of 296,314 shares. The stock had previously closed at $39.92.

Analysts Set New Price Targets

Several brokerages recently weighed in on PAHC. Weiss Ratings lowered Phibro Animal Health from a "buy (b-)" rating to a "hold (c+)" rating in a research note on Monday, June 15th. Wall Street Zen lowered Phibro Animal Health from a "strong-buy" rating to a "buy" rating in a report on Saturday, May 9th. Zacks Research cut Phibro Animal Health from a "strong-buy" rating to a "hold" rating in a research report on Thursday, May 21st. Finally, Citigroup reduced their target price on Phibro Animal Health from $62.00 to $44.00 and set a "neutral" rating for the company in a research note on Thursday, May 14th. One research analyst has rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, Phibro Animal Health has an average rating of "Hold" and a consensus target price of $47.67.

Phibro Animal Health Stock Performance

The company has a current ratio of 2.96, a quick ratio of 1.27 and a debt-to-equity ratio of 1.84. The firm's 50-day moving average is $34.62 and its two-hundred day moving average is $41.95. The stock has a market cap of $1.56 billion, a price-to-earnings ratio of 15.79, a P/E/G ratio of 1.11 and a beta of 0.46.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last posted its quarterly earnings data on Wednesday, August 26th. The company reported $0.85 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.71 by $0.14. Phibro Animal Health had a return on equity of 37.86% and a net margin of 6.57%.The company had revenue of $396.75 million for the quarter, compared to analysts' expectations of $381.18 million. Phibro Animal Health has set its FY 2027 guidance at 3.410-3.590 EPS. As a group, sell-side analysts expect that Phibro Animal Health Corporation will post 3.51 earnings per share for the current year.

Phibro Animal Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Wednesday, September 2nd will be given a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 1.2%. The ex-dividend date of this dividend is Wednesday, September 2nd. Phibro Animal Health's payout ratio is presently 19.67%.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of PAHC. Cetera Investment Advisers lifted its holdings in shares of Phibro Animal Health by 2.7% in the 1st quarter. Cetera Investment Advisers now owns 10,997 shares of the company's stock worth $608,000 after acquiring an additional 293 shares during the last quarter. 1620 Investment Advisors Inc. raised its holdings in Phibro Animal Health by 77.4% in the fourth quarter. 1620 Investment Advisors Inc. now owns 676 shares of the company's stock valued at $25,000 after acquiring an additional 295 shares in the last quarter. JPMorgan Chase & Co. lifted its position in shares of Phibro Animal Health by 2.9% during the 2nd quarter. JPMorgan Chase & Co. now owns 13,005 shares of the company's stock worth $332,000 after purchasing an additional 363 shares during the last quarter. Farther Finance Advisors LLC boosted its position in shares of Phibro Animal Health by 113.2% during the 4th quarter. Farther Finance Advisors LLC now owns 727 shares of the company's stock worth $27,000 after acquiring an additional 386 shares in the last quarter. Finally, KBC Group NV purchased a new position in Phibro Animal Health in the first quarter valued at approximately $29,000. Hedge funds and other institutional investors own 99.34% of the company's stock.

About Phibro Animal Health

Phibro Animal Health Corporation NASDAQ: PAHC is a diversified global animal health and mineral nutrition company headquartered in Teaneck, New Jersey. The company develops, manufactures and markets a broad range of pharmaceutical, mineral nutrition and performance products designed to support the health and productivity of livestock, companion animals and aquaculture species. Phibro's portfolio includes vaccines, anti-infective therapies, coccidiostats, disinfectants, premix minerals and specialty feed additives aimed at enhancing growth, immunity and overall animal well-being.

The company operates through three principal business segments: Animal Health, Mineral Nutrition and Performance Products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source